Company page

Equillium, Inc.

Equillium, Inc. is a public company traded under the ticker EQ in the American market, with a market capitalization of approximately $192.8 million. The company focuses on developing innovative therapies for severe autoimmune and inflammatory diseases. Equillium aims to address unmet medical needs through its research and product development initiatives.